{"id":"NCT02682381","sponsor":"Shire","briefTitle":"Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition","officialTitle":"A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-23","primaryCompletion":"2017-08-18","completion":"2017-08-18","firstPosted":"2016-02-15","resultsPosted":"2018-10-16","lastUpdate":"2021-06-09"},"enrollment":59,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide 0.05mg/kg","otherNames":[]},{"type":"DRUG","name":"Teduglutide 0.025 mg/kg","otherNames":[]},{"type":"OTHER","name":"Standard of Care","otherNames":[]}],"arms":[{"label":"0.025 mg/kg/day Teduglutide","type":"EXPERIMENTAL"},{"label":"0.05 mg/kg/day Teduglutide","type":"EXPERIMENTAL"},{"label":"Standard of care","type":"ACTIVE_COMPARATOR"}],"summary":"Teduglutide is approved for treatment of adults with short bowel syndrome (SBS). The purpose of this study is to evaluate the safety and efficacy of teduglutide in children up to the age of 17 with SBS who are dependent on parenteral support. Subjects may choose whether to receive the study drug or to participate in a standard-of-care arm. All participants who complete the study may be eligible to receive the study drug in a long-term extension study.","primaryOutcome":{"measure":"Number of Participants Who Achieved at Least a 20 Percent (%) Reduction in Weight-Normalized Average Daily Parenteral Nutrition Intravenous (PN/IV) Volume at Week 24","timeFrame":"Baseline through Week 24","effectByArm":[{"arm":"0.025 mg/kg/Day Teduglutide","deltaMin":13,"sd":null},{"arm":"0.05 mg/kg/Day Teduglutide","deltaMin":18,"sd":null},{"arm":"Standard of Care","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"0 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":27,"countries":["United States","Belgium","Canada","Finland","Germany","Italy","United Kingdom"]},"refs":{"pmids":["37889619"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":24},"commonTop":["Vomiting","Upper respiratory tract infection","Cough","Pyrexia","Nasopharyngitis"]}}